Status:
COMPLETED
Ancillary Study of the ULTREC Project
Lead Sponsor:
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Conditions:
Deep Vein Thrombosis
Eligibility:
All Genders
18+ years
Brief Summary
The ULTREC research project is designed to assess the safety of a negative strategy relying on Colour Doppler Ultrasound (CDUS) for excluding the diagnosis of a new thrombosis. The ULTREC project does...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Known history of objectively documented deep vein thrombosis of the lower limb (with or without pulmonary embolism)
- Out-patients referred for clinically suspected acute recurrent ipsilateral DVT of the lower limb
- Patients covered by social security or an equivalent regimen
- No objection to the use of the data
- Inclusion in the ULTREC study
Exclusion
- Known current pregnancy
- Any condition, which may prevent from performing the colour doppler ultrasound test
- Delay from onset of symptoms to inclusion of more than 10 days
- Therapeutic anticoagulation for more than 48 hours in the two days prior to consent to ULTREC Study
- Presence of clinical symptoms or signs of pulmonary embolism
- Life expectancy less than 3 months
- Patient unable to adhere to ULTREC protocol follow-up
- Participants under judicial protection or incapacity
Key Trial Info
Start Date :
November 29 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 24 2023
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT05300139
Start Date
November 29 2021
End Date
January 24 2023
Last Update
November 20 2025
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Cabinet d'angiologie Cazanave
Carcassonne, Aude, France, 11000
2
Centre Hospitalier de Carcassonne
Carcassonne, Aude, France, 11000
3
Cabinet d'angiologie Dias
Martigues, Bouches Du Rhône, France, 13500
4
Cabinet d'angiologie De Mari
Ajaccio, Corse-du-Sud, France, 20090